Sessions Tells DEA To Study Opioid Production Quotas, Consider Cuts
The DEA annually sets the production and manufacturing quotas for Schedule I and II controlled substances. Between 1993 and 2015, the DEA approved a 39-fold increase of oxycodone, 12-fold increase of hydrocodone and a 25-fold increase of fentanyl.